The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Amedisys Inc. shares valued at $510,628 were sold by North Michael Paul on Mar 03. At $86.43 per share, North Michael Paul sold 5,908 shares. The insider’s holdings dropped to 4,164 shares worth approximately $0.32 million following the completion of this transaction.
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
Also, Bohnert Denise M. sold 557 shares, netting a total of over 64,055 in proceeds. Following the sale of shares at $115.00 each, the insider now holds 11,850 shares.
Analyzing AMED Stock Performance
On Thursday, Amedisys Inc. [NASDAQ: AMED] plunged -0.66% to $76.75. The stock’s lowest price that day was $75.23, but it reached a high of $76.97 in the same session. During the last five days, there has been a surge of approximately 0.41%. Over the course of the year, Amedisys Inc. shares have dropped approximately -8.13%. Shares of the company reached a 52-week high of $106.01 on 02/16/23 and a 52-week low of $69.36 on 03/23/23. A 50-day SMA is recorded $76.74, while a 200-day SMA reached $91.65. Nevertheless, trading volume fell to 0.6 million shares from 0.26 million shares the previous day.
Support And Resistance Levels for Amedisys Inc. (AMED)
According to the 24-hour chart, there is a support level at 75.66, which, if violated, would cause prices to drop to 74.58. In the upper region, resistance lies at 77.40. The next price resistance is at 78.06. RSI (Relative Strength Index) is 47.36 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.40, which suggests the price will decrease in the coming days. Percent R is at 54.37%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
Is Amedisys Inc. subject to short interest?
Stocks of Amedisys Inc. saw a sharp rise in short interest on Apr 27, 2023 jumping by 0.24 million shares to 2.14 million. Data from Yahoo Finance shows that the short interest on Mar 30, 2023 was 1.9 million shares. A jump of 11.21% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 5.46 of the overall float, the days-to-cover ratio (short ratio) jumped to 5.46.
Which companies own the most shares of Amedisys Inc. (AMED)?
According to The Vanguard Group, Inc. filings, the company currently owns 3,184,986 shares, which is about 9.79% of the total AMED shares outstanding. The investor’s shares have appreciated by 99,614 from its previous 13-F filing of 3085372.0 shares. With the completion of the sale transaction, BlackRock Fund Advisors’s stake is now worth $216,322,178. Wellington Management Co. LLP reduced a -7.26% interest valued at $208.74 million while Deerfield Management Co. LP purchased a 310,821 stake. A total of 153,989 shares of Amedisys Inc. were bought by JPMorgan Investment Management, I during the quarter, and -582 were sold by Riverbridge Partners LLC. In its current portfolio, Mackenzie Financial Corp. holds 1,041,580 shares valued at $83.64 million.
In terms of Amedisys Inc. share price expectations, FactSet research, analysts set an average price target of $93.92 in the next 12 months, up nearly 21.67% from the previous closing price of $77.26. Analysts anticipate Amedisys Inc. stock to reach $115.00 by 2023, with the lowest price target being $73.00. In spite of this, 14 analysts ranked Amedisys Inc. stock as an Overweight at the end of 2023.